PT67268A - Process for preparing the antibiotic 890a10 and the pharmaceutically acceptable salts thereof - Google Patents

Process for preparing the antibiotic 890a10 and the pharmaceutically acceptable salts thereof

Info

Publication number
PT67268A
PT67268A PT67268A PT6726877A PT67268A PT 67268 A PT67268 A PT 67268A PT 67268 A PT67268 A PT 67268A PT 6726877 A PT6726877 A PT 6726877A PT 67268 A PT67268 A PT 67268A
Authority
PT
Portugal
Prior art keywords
antibiotic
preparing
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Application number
PT67268A
Other languages
Portuguese (pt)
Other versions
PT67268B (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PT67268A publication Critical patent/PT67268A/en
Publication of PT67268B publication Critical patent/PT67268B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT67268A 1976-11-17 1977-11-11 Process for preparing the antibiotic 890a10 and the pharmaceutically acceptable salts thereof PT67268B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74295876A 1976-11-17 1976-11-17

Publications (2)

Publication Number Publication Date
PT67268A true PT67268A (en) 1977-12-01
PT67268B PT67268B (en) 1979-10-08

Family

ID=24986929

Family Applications (1)

Application Number Title Priority Date Filing Date
PT67268A PT67268B (en) 1976-11-17 1977-11-11 Process for preparing the antibiotic 890a10 and the pharmaceutically acceptable salts thereof

Country Status (10)

Country Link
JP (1) JPS5363397A (en)
CH (1) CH634104A5 (en)
DE (1) DE2751303A1 (en)
DK (1) DK487977A (en)
ES (1) ES463973A1 (en)
FR (1) FR2371448A1 (en)
GB (1) GB1595233A (en)
NL (1) NL7712092A (en)
PT (1) PT67268B (en)
SE (1) SE433621B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16708A (en) 1978-07-24 1984-01-20 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1483142A (en) * 1975-03-15 1977-08-17 Beecham Group Ltd Streptomycetal antibiotic
CH633554A5 (en) * 1975-11-21 1982-12-15 Merck & Co Inc Process for the preparation of novel thienamycin derivatives.

Also Published As

Publication number Publication date
FR2371448B1 (en) 1980-03-14
CH634104A5 (en) 1983-01-14
PT67268B (en) 1979-10-08
JPS6310998B2 (en) 1988-03-10
GB1595233A (en) 1981-08-12
SE433621B (en) 1984-06-04
DE2751303A1 (en) 1978-05-18
JPS5363397A (en) 1978-06-06
FR2371448A1 (en) 1978-06-16
NL7712092A (en) 1978-05-19
ES463973A1 (en) 1978-11-16
DK487977A (en) 1978-05-18
SE7712430L (en) 1978-05-18

Similar Documents

Publication Publication Date Title
PT65934B (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
HU173105B (en) Process for preparing 1-nitro-9-dialkylamino-isoalkylamino-acridines and salts thereof
ZA775361B (en) Uracil derivatives and process for the preparation thereof
JPS52118493A (en) Cephalospoline derivatives and process for preparing same
JPS52153993A (en) Betaalactum antibiotics and process for preparing same
PH15913A (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
IL52099A (en) 5,6-dihydroprostacyclin derivatives and process for their preparation
GB1538206A (en) N2-arylsulphonyl-l-argininamides and the pharmaceutically acceptable salts thereof
PT67267B (en) Process for preparing the antibiotic 890a9 and the pharmaceutically acceptable salts thereof
IL52488A (en) 9-desacetyl daunoruiin derivatives and process for their preparation
ZA773025B (en) Uracil derivatives and process for the preparation thereof
HU174978B (en) Process for producing pharmaceutically active isothiourea derivatives
ZA794581B (en) N 2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
PT67268A (en) Process for preparing the antibiotic 890a10 and the pharmaceutically acceptable salts thereof
GB1518443A (en) Indolizine derivatives and process for preparing the same
GB1538843A (en) Neamine derivative and process for preparing the same
YU166877A (en) Process for preparing cefalotin and pharmaceutically acceptable salt thereof
IL52595A (en) Azetidine derivatives and processes for preparing the same
IL60587A0 (en) New halogenated 15-hydroxy-e-homoeburnane derivatives and a process for the preparation thereof
GB1538207A (en) N2-arylsulphonyl-l-argininamides and the pharmaceutically acceptable salts thereof
IL51277A (en) Antibiotic a-7413 and process for preparation thereof
PH13054A (en) 3-fluoro-d-alanine and pharmaceutically acceptable salts thereof and process for their preparation
JPS5363395A (en) Cephem derivative and process for preparing same
HU174186B (en) Process for preparing l 13365 antibiotic
HU177869B (en) Process for preparing garamine and garamine derivatives